Skip to Content


Office of Biotechnology Activities, Office of Science Policy, Office of the Director; Notice of Meeting

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of the National Science Advisory Board for Biosecurity (NSABB). Under authority 42 U.S.C. 217a, Section 222 of the Public Health Service Act, as amended, the Department of Health and Human Services established NSABB to provide advice, guidance and leadership regarding federal oversight of dual use research, defined as biological research with legitimate scientific purposes that could be misused to pose a biological threat to public health and/or national security.

The meeting will be open to the public, however pre-registration is strongly recommended due to space limitations. Persons planning to attend should register online at​meetings.asp or by calling Capital Consulting Corporation (Contact: Saundra Bromberg at 301-468-6004, ext. 406). Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should indicate these requirements upon registration.

Name of Committee: National Science Advisory Board for Biosecurity

Date: December 10, 2008

Open: 8:30 a.m. to 6 p.m.

Agenda: Presentations and discussions regarding: (1) Preliminary findings and recommendations on strategies to optimize programs of personnel reliability for individuals with access to select agents and toxins; (2) brief overview of Public Start Printed Page 70357Consultation meeting in July 2008 on the proposed framework for the oversight of dual use research; (3) brief update on the activities of the Working Group on Outreach and Education; (4) brief update on Synthetic Genomics; (5) highlights from the November 2008 International Roundtable on Sustaining Progress in the Life Sciences: Strategies for Managing Dual Use Research of Concern; (6) public comments; and (7) other business of the Board.

Place: The Legacy Hotel & Meeting Centre, 1775 Rockville Pike, Rockville, MD 20852.

Contact Person: Ronna Hill, NSABB Program Assistant, 6705 Rockledge Drive, Bethesda, Maryland 20892, (301) 496-9838.

This meeting will also be webcast. The draft meeting agenda and other information about NSABB, including information about access to the Web cast and pre-registration, will be available at​meetings.asp. Please check the OBA Web site for updates. Times are approximate and subject to change.

Any member of the public interested in presenting oral comments at the meeting may notify the Contact Person listed on this notice at least 10 days in advance of the meeting. Interested individuals and representatives of an organization may submit a letter of intent, a brief description of the organization represented and a short description of the oral presentation. Only one representative of an organization may be allowed to present oral comments. Both printed and electronic copies are requested for the record. In addition, any interested person may file written comments with the committee. All written comments must be received by December 1, 2008 and should be sent via e-mail to with “NSABB Public Comment” as the subject line or by regular mail to 6705 Rockledge Drive, Suite 750, Bethesda, MD 20892, Attention Ronna Hill. The statement should include the name, address, telephone number and, when applicable, the business or professional affiliation of the interested person.

Start Signature

Dated: November 13, 2008.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

End Signature End Preamble

[FR Doc. E8-27532 Filed 11-19-08; 8:45 am]